Genpharmasec Ltd.

BOM:GENPHARMAHealthcare

₹1.01+0.00%At closeAt close · Wed 21 Oct · ≈ AED 0.0390 · Market cap $5.88M

INR billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Revenue	0.2	0.3	0.3	0.3	0.3	1.4	1.8	+26.9%
Cost of revenue	0.2	0.3	0.2	0.3	0.3	1.3	1.7	+27.7%
Gross profit	0.0	0.0	0.0	0.1	0.0	0.1	0.1	+7.3%
Research & development	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Selling, general & administrative	0.0	0.0	0.0	0.0	0.0	0.1	—	—
Selling & marketing	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Operating expenses	0.0	0.0	0.0	0.1	0.0	0.1	0.1	+12.5%
Operating income	0.0	(0.0)	0.0	0.0	(0.0)	(0.0)	(0.0)	−41.3%
Interest expense	0.0	0.0	0.0	0.0	0.0	0.0	0.0	+22.3%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	—
Other income / expense	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Pre-tax income	0.0	(0.0)	0.0	0.0	0.0	0.0	(0.0)	−101.8%
Income tax	0.0	(0.0)	(0.0)	0.0	0.0	0.0	0.0	+97.5%
Net income	0.0	(0.0)	0.0	(0.0)	0.0	0.0	(0.0)	−107.6%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other net income adjustments	0.0	0.0	0.0	(0.0)	0.0	0.0	—	—
EPS, basic (per share)	0.03	(0.00)	0.02	(0.00)	0.02	0.01	(0.00)	−122.0%
EPS, diluted (per share)	0.03	(0.00)	0.02	(0.00)	0.02	0.01	(0.00)	−122.0%
EBITDA	0.0	(0.0)	0.0	0.0	0.0	0.0	0.0	−71.7%
Depreciation & amortization	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Weighted average shares (shares)	451,772,256	461,080,429	461,082,644	497,399,940	553,719,700	1,603,300,000	—	—
Weighted average diluted shares (shares)	451,772,256	461,080,429	461,082,644	497,399,940	553,719,700	1,603,300,000	—	—
Gross margin	6.7%	1.8%	6.1%	17.7%	12.4%	3.8%	3.2%	−0.6 pts
Operating margin	3.2%	−2.0%	0.9%	0.0%	−2.2%	−0.7%	−0.8%	−0.1 pts
Net margin	6.0%	−0.8%	4.4%	−0.4%	3.7%	1.1%	−0.1%	−1.2 pts

INR billionsUpdated Tue 30 Jun ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.

TTM ends 2026-06-30 and uses four consecutive reported quarters.